Israel 's MyHeritage has launched a single health and ancestry test , becoming the latest ancestry DNA firm to expand into health monitoring after competitors like 23andMe . The test produces genetic data on diseases including type 2 diabetes , hereditary breast cancer , heart disease , late - onset Alzheimer ’s disease , late - onset Parkinson ’s disease , Tay - Sachs disease and cystic fibrosis . The $ 199 kits are processed in a laboratory certified under US Clinical Laboratory Improvement Amendments regulations , but the test has reportedly not been approved by the Food and Drug Administration . even the design of the test kit box is similar. In the US , MyHeritage is working with PWNHealth to offer counselling and contact with medical professionals .
Israel 's MyHeritage has launched a single health and ancestry test , becoming the latest ancestry DNA firm to expand into health monitoring after competitors like 23andMe . The test produces genetic data on diseases including type 2 diabetes , hereditary breast cancer , heart disease , late - onset Alzheimer ’s disease , late - onset Parkinson ’s disease , Tay - Sachs disease and cystic fibrosis . The $ 199 kits are processed in a laboratory certified under US Clinical Laboratory Improvement Amendments regulations , but the test has reportedly not been approved by the Food and Drug Administration . In the US , MyHeritage is working with PWNHealth to offer counselling and contact with medical professionals .